Novartis | NOVN - Ordinary Share Capital

Stock Price
126.46
Daily Change
-0.02 -0.02%
Monthly
10.60%
Yearly
28.84%
Q1 Forecast
123.39

Novartis reported $1.94B in Ordinary Share Capital for its fiscal quarter ending in June of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Alcon AG USD 494.6M 0 Sep/2025
Almirall EUR 214.79M 154.21 Jun/2025
Amgen USD 539M 1000K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
Autolus Therapeutics Ltd USD 266.14M 16.07K Jun/2025
Bayer EUR 982.42M 0 Sep/2025
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Fresenius EUR 563.24M 0 Sep/2025
Fresenius Medical Care EUR 289.85M 3.56M Sep/2025
Galapagos EUR 65.9M 0 Sep/2025
Genmab DKK 10M 56M Mar/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
GRIFOLS EUR 679.73M 0 Sep/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
J&J USD 2.41B 584K Sep/2025
Lonza CHF 72M 0 Dec/2024
Merck EUR 434.78M 130.22M Jun/2025
Merck USD 2.49B 15.79M Sep/2025
Novartis USD 1.94B 23.4M Jun/2025
Novartis USD 1.92B 17.06M Sep/2025
Novo Nordisk DKK 4.44B 0 Dec/2025
Orion EUR 140.69M 0 Sep/2025
Pfizer USD 5.69B 1000K Sep/2025
Philips EUR 951.29M 310K Dec/2025
Recordati EUR 205.83M 270K Sep/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
UCB EUR 584M 0 Dec/2024